Diabetes may start in the intestines, research suggests

In mice without the key enzyme, fatty acid synthase, bad bacteria invade the colon and the small intestine, which creates the inflammation underlying insulin resistance and diabetes. In the mouse colon above, a protein (shown in red) that makes up the protective membrane in the gut is not functioning properly. Credit: Washington University School of Medicine

Scientists at Washington University School of Medicine in St. Louis have made a surprising discovery about the origin of diabetes. Their research suggests that problems controlling blood sugar — the hallmark of diabetes — may begin in the intestines.

The new study, in mice, may upend long-held theories about the causes of the disease. Because insulin is produced in the pancreas and sugar is stored in the liver, many scientists have looked to those organs for the underlying causes of .

The findings are reported Feb. 16 in the journal Cell Host & Microbe.

In the new research, scientists studied mice that are unable to make fatty acid synthase (FAS) in the intestine. FAS, an enzyme crucial for the production of lipids, is regulated by insulin, and people with diabetes have defects in FAS. Mice without the enzyme in the intestines develop chronic inflammation in the gut, a powerful predictor of diabetes.

"Diabetes may indeed start in your gut," says principal investigator Clay F. Semenkovich, MD. "When people become resistant to insulin, as happens when they gain weight, FAS doesn't work properly, which causes inflammation that, in turn, can lead to diabetes."

This video is not supported by your browser at this time.
Mice with defects in their ability to make the enzyme fatty acid synthase in their intestines develop inflammation, and diabetes. In a new study, Washington University researchers made the surprising discovery that diabetes may get its start in the intestines, rather than in the pancreas or the liver. The culprit is that inflammation related to not having fatty acid synthase in gut tissues. Jim Dryden has more… Credit: Washington University BioMed Radio

First author Xiaochao Wei, PhD, and Semenkovich, the Herbert S. Gasser Professor of Medicine, professor of cell biology and physiology and director of the Division of Endocrinology, Metabolism and Lipid Research, collaborated with specialists in gastroenterology and genome sciences to determine what happens in mice that can't make FAS in their intestines.

"The first striking thing we saw was that the mice began losing weight," says Wei, a research instructor in medicine. "They had diarrhea and other gastrointestinal symptoms, and when we looked closely at the tissue in the gut, we found a lot of inflammation."

Initially, the researchers thought that the mice became sick because of changes to the mix of microbes that naturally live in the gut, where they help digest food and synthesize vitamins.

In collaboration with Jeffrey I. Gordon, MD, director of the Center for Genome Sciences and Systems Biology at the School of , they looked more closely at gut microbes in the mice.

"The mice had substantial changes in their gut microbiome," Semenkovich says. "But it wasn't the composition of microbes in the gut that caused the problems."

Instead, Wei says, the mice got sick because of a defect in fatty acid synthase. The mice without fatty acid synthase had lost the protective lining of mucus in the intestines that separates the microbes from direct exposure to cells. This allowed bacteria to penetrate otherwise healthy cells in the gut, making the mice sick.

In a further collaboration with Nicholas O. Davidson, MD, director of the Division of Gastroenterology, the researchers found gastrointestinal effects resembling some features of inflammatory bowel disease. Other investigators studying humans with ulcerative colitis had previously made the unexplained observation that colon biopsies from these patients have low amounts of fatty acid synthase.

"Fatty acid synthase is required to keep that mucosal layer intact," Wei says. "Without it, bad bacteria invade cells in the colon and the small intestine, creating inflammation, and that, in turn, contributes to insulin resistance and diabetes."

Inflammation and insulin resistance reinforce each other. Inflammatory substances can cause insulin resistance and inhibit the production of insulin, both of which interfere with the regulation of . In turn, is known to promote inflammation.

Further study showed that the ability to build the thin, but important, layer of mucosal cells was hindered by faulty FAS.

That the is so important to the development of diabetes makes sense because many people with the condition not only have faulty FAS, but they also frequently develop gastrointestinal difficulties, Semenkovich says.

"Abdominal pain and diarrhea are some of the most common problems we see in people with diabetes," he says. "We could only connect these 'dots' because other experts at the university could help us link what we observed in these mice to what occurs in patients with diabetes and inflammatory bowel disease," Semenkovich says.

Semenkovich and Wei say much more study is needed, but they say that FAS and a key component of the intestinal mucosa called Muc2 may be potential targets for diabetes therapy. They now plan to study people with diabetes to see whether FAS is altered in a similar way, producing damage to the mucosal layer in the intestines.

More information: Wei X, Yang Z, Rey FE, Ridaura VK, Davidson, NO, Gordon JI, Semenkovich CS, Fatty acid synthase modulates intestinal barrier function through palmitoylation of mucin2. Cell Host & Microbe, Feb. 16, 2012.

Related Stories

Enzyme boosts metabolism, prevents weight gain in mice

Nov 14, 2011

In a new study, scientists report that they substantially curbed weight gain, improved metabolism, and improved the efficacy of insulin in mice by engineering them to express a specific human enzyme in their fat tissue. Although ...

Tale of 2 mice pinpoints major factor for insulin resistance

May 16, 2011

The road to type 2 diabetes is paved with insulin resistance, a condition often associated with obesity in which the hormone begins to fail at its job helping to convert sugars to energy. Researchers at Joslin Diabetes Center ...

Recommended for you

Magnesium cuts diabetes risk

23 hours ago

Getting enough magnesium in the diet may reduce the risk of diabetes, especially for those who already show signs of heading that way.

Personalised treatment for stress-related diabetes

Oct 14, 2014

Researchers at Lund University in Sweden are testing a treatment for type 2 diabetes which targets the disease mechanism itself - and not just the symptoms. For the first time, knowledge about the individual patient's genetic ...

Sensors to simplify diabetes management

Oct 13, 2014

For many patients diagnosed with diabetes, treating the disease can mean a burdensome and uncomfortable lifelong routine of monitoring blood sugar levels and injecting the insulin that their bodies don't ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

axcohn
not rated yet Feb 15, 2012
"...they say that FAS and a key component of the intestinal mucosa called Muc2 may be potential targets for diabetes therapy."

Why bother spending time and money on novel diabetes therapies when the world already has a free diabetes therapy: carbohydrate restriction? Every clinical study ever performed on this subject has showed marked improvement of diabetic symptoms on a low-carb diet. Type 2 diabetics, in particular, usually become asymptomatic within 90 days, and have lab results, e.g., HbA1c, within the range of normal after 6 months, allowing them to stop taking reduce or stop taking diabetes medication, e.g., insulin, metformin.
Fed_Up_With_Stupid
1 / 5 (1) Feb 15, 2012
Two reasons come to mind:

1. It takes a level of disciple that most people lack
2. It is difficult to make money selling a carbohydrate restricted diet to people, but it would be very easy to make money selling them a drug.
tjcoop3
1 / 5 (1) Feb 16, 2012
I guess my question would be that if this is also true in humans what nutritional deficiency is present which is the cause of this "fas"?
Get to that and you don't have to be concerned about DIE ts or drugs. One just eats correctly.
I have seen much improvement in my condition since changing what I eat to more healthy choices. My Dr. is even talking about taking me completely off of insulin after having taken a whole bottle a day a few years ago. (Very Insulin resistant)
I still weigh 420lbs but am gradually losing. So it is what you eat not a bunch of restrictions. I still eat plenty. BTW most of my weight gain came after I got diabetes from medication side effects. Almost 150 lbs in 8 yrs. I am now working to get that off. I am also NOT planning to have some drastic surgery that might make me even worse. Natural, gradual is the best way. I have no heart disease or other stuff because I eat right and don't follow recommended DIE ts.
kochevnik
1 / 5 (1) Feb 20, 2012
Not only carbs but grasses like corn and wheat specifically. Wheat is linked with inflammatory bowel disease, blocks nutrient absorption by sticking to the intestines, and spikes blood sugar i.e. it is highly glycemic. It's also high in cadmium.

Man hasn't evolved to eat grasses since they are a result of farming, which only began 30,000 years ago. In humans there was a massive die-off initially, and humans that survived farming showed marked signs of malnutrition. My body can handle carbs just not the grasses that are best handled with four stomachs.